Robert N. Atkinson

A-803467, a potent and selective Na _v 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

Michael F. Jarvis, Prisca Honoré, Char‐Chang Shieh et al. · Proceedings of the National Academy of Sciences · 2007 · 514 citations · Full text

Identification of the First <i>trans</i>-(3<i>R</i>,4<i>R</i>)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist Activity

James B. Thomas, Robert N. Atkinson, Richard B. Rothman et al. · Journal of Medicinal Chemistry · 2001 · 105 citations · Full text

Discovery and Biological Evaluation of 5-Aryl-2-furfuramides, Potent and Selective Blockers of the Na_v1.8 Sodium Channel with Efficacy in Models of Neuropathic and Inflammatory Pain

Michael E. Kort, Irene Drizin, Robert J. Gregg et al. · Journal of Medicinal Chemistry · 2008 · 83 citations · Full text

Pain Disorders, Pain Medicine, Neuropathic Pain +20

Percutaneous Kirschner Wire Stabilisation following Closed Reduction of Colles’ Fractures

E. T. Mah, Robert N. Atkinson · Journal of Hand Surgery (European Volume) · 1992 · 79 citations

Identification of (3<i>R</i>)-7-Hydroxy-<i>N</i>-((1<i>S</i>)-1-{[(3<i>R</i>,4<i>R</i>)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a Novel Potent and Selective Opioid κ Receptor Antagonist

James B. Thomas, Robert N. Atkinson, N. Ariane Vinson et al. · Journal of Medicinal Chemistry · 2003 · 75 citations · Full text